2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- 48.76%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Procyon (PCYN)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 10/27/2026
Company Profile
Procyon Corporation, together with its subsidiaries, engages in manufacturing and marketing of wound and skin care products in the United States. The company offers skin and wound care products made with antimicrobial agent under the AMERIGEL hydrogel wound dressing, AMERIGEL post-op surgical kit, AMERIGEL saline wound wash, AMERIGEL care lotion, and AMERIGEL barrier lotion names, as well as EXTREMIT-EASE name. It also provides HELIX3-CP Collagen Powder and HELIX3-CM Collagen Matrix; AMERX wound care kits, AMERX calcium alginate dressings, AMERX foam dressings, AMERX bordered foam dressings, AMERX bordered gauze dressings, AMERX hydrocolloid dressings, and AMERX thin hydrocolloid dressings; and Oakin, which provides healing in wound and problematic skin conditions. The company serves physicians, healthcare providers, hospitals, clinics, institutions, and schools. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.
Key Executives
- Justice W. Anderson
- James Anderson
- George Otis Borak
Current Ownership Distribution
- Insiders7.4M (90.92%)
- Mutual Funds385,629 (4.75%)
- Other351,821 (4.33%)
- Institutions0 (0.00%)